Pityriasis rosea following SARS-CoV-2 vaccination: A case series.

Temiz, Selami Aykut; Abdelmaksoud, Ayman; Dursun, Recep; Durmaz, Koray; Sadoughifar, Roxanna; Hasan, Abdulkarim

Temiz, Selami Aykut; Abdelmaksoud, Ayman; Dursun, Recep; Durmaz, Koray; Sadoughifar, Roxanna; Hasan, Abdulkarim.

Temiz SA; Department of Dermatology, Konya Eregli State Hospital, Konya, Turkey.
Abdelmaksoud A; Mansoura Dermatology, Venerology and Leprology Hospital, Mansoura, Egypt.
Dursun R; Department of Dermatology, Necmettin Erbakan University Meram Medical Faculty, Konya, Turkey.
Durmaz K; Department of Dermatology, Bozüyük State Hospital, Bilecik, Turkey.
Sadoughifar R; Department of Dermatology, University of Rome G. Marconi, Rome, Italy.
Hasan A; Department of Pathology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.

J Cosmet Dermatol ; 20(10): 3080-3084, 2021 Oct.

Article in English | MEDLINE | ID: covidwho-1345995

Subject(s)

COVID-19; Pityriasis Rosea; COVID-19 Vaccines; Humans; Pityriasis Rosea/etiology; SARS-CoV-2; Vaccination

Keywords

COVID-19; pityriasis rosea; vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pityriasis Rosea / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Cosmet Dermatol Journal subject: Dermatology Year: 2021 Document Type: Article Affiliation country: Jocd.14372

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google